2-(2-{[({[(2S)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl}carbamoyl)methyl]sulfanyl}-1,3-thiazol-4-yl)acetic acid
Structure Info
- Chemspace ID
- CSSB02495324862 (In-Stock Building Blocks)
- MFCD
- MFCD31382095
- IUPAC Name
- 2-(2-{[({[(2S)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl}carbamoyl)methyl]sulfanyl}-1,3-thiazol-4-yl)acetic acid
- Mol formula
- C19H21Cl2N3O4S2
- Mol weight
- 490 Da
- Catalog Number(s)
- 329516, 879399-82-3, A1177754, AA01EOIB, ACCOKR430, AG01EOL3, AR01EPA3, AX64463, BD01129202, BUP16239, EC01EQQV, H38356, HY-U00331, M32754, ST01EQ1V, T10156, TS-07668, TX01EPQR, Y225838, Y3105061, Y4262873, ZXC333737
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.5
- Heavy atoms count
- 30
- Rotatable bond count
- 9
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.421
- Polar surface area (Å)
- 92
- Hydrogen bond acceptors count
- 6
- Hydrogen bond donors count
- 2
![Chemical structure of 2-(2-{[({[(2S)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl}carbamoyl)methyl]sulfanyl}-1,3-thiazol-4-yl)acetic acid (C19H21Cl2N3O4S2) - CSSB02495324862](/st/structure/200/571f1bcbacee36d241b3687bc0d39471/OC%2528%253DO%2529CC1%253DCSC%2528SCC%2528%253DO%2529NC%255BC%2540H%255D2CN%2528CC3%253DCC%253DC%2528Cl%2529C%2528Cl%2529%253DC3%2529CCO2%2529%253DN1.png "C19H21Cl2N3O4S2")
- Zoom the structure
- CSSB02495324862
Items Overall 57 items from 13 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BLD Pharmatech Co., Limited (15% Off · Special Offer) | 1 day | United States To: | 99 | 10 mg | 206.00 | |
| BLD Pharmatech Co., Limited (15% Off · Special Offer) | 1 day | United States To: | 99 | 25 mg | 390.00 | |
| BLD Pharmatech Co., Limited (15% Off · Special Offer) | 1 day | United States To: | 99 | 50 mg | 662.00 | |
| BLD Pharmatech Co., Limited (15% Off · Special Offer) | 1 day | United States To: | 99 | 100 mg | 1,125.00 | |
Description: Name:(S)-2-(2-((2-(((4-(3,4-Dichlorobenzyl)morpholin-2-yl)methyl)amino)-2-oxoethyl)thio)thiazol-4-yl)acetic acid; CAS: 879399-82-3 | ||||||
| 1st Scientific LLC | 3 days | United States To: | 99 | 5 mg | 104.50 | |
| 1st Scientific LLC | 3 days | United States To: | 99 | 10 mg | 166.10 | |
| 1st Scientific LLC | 3 days | United States To: | 99 | 25 mg | 313.50 | |
| 1st Scientific LLC | 3 days | United States To: | 99 | 50 mg | 532.40 | |
Description: CCR3 antagonist 1; CAS: 879399-82-3 | ||||||
| BLD PHARMATECH LTD CN | 7 days | China To: | 99 | 5 mg | 129.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 99 | 10 mg | 206.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 99 | 25 mg | 390.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 99 | 50 mg | 662.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 99 | 100 mg | 1,125.00 | |
Description: Name:(S)-2-(2-((2-(((4-(3,4-Dichlorobenzyl)morpholin-2-yl)methyl)amino)-2-oxoethyl)thio)thiazol-4-yl)acetic acid; CAS: 879399-82-3 | ||||||
| Angene International Limited | 10 days | China To: | 90 | 1 mg | 84.60 | |
| Angene International Limited | 10 days | China To: | 90 | 5 mg | 191.70 | |
| Angene International Limited | 10 days | China To: | 90 | 10 mg | 292.50 | |
| Angene International Limited | 10 days | China To: | 90 | 25 mg | 458.10 | |
| Angene International Limited | 10 days | China To: | 90 | 50 mg | 616.50 | |
| Angene International Limited | 10 days | China To: | 90 | 100 mg | 846.00 | |
Description: CCR3 antagonist 1; CAS: 879399-82-3 | ||||||
| AiFChem CN | 10 days | China To: | 99 | 10 mg | 190.00 | |
| AiFChem CN | 10 days | China To: | 99 | 25 mg | 359.00 | |
| AiFChem CN | 10 days | China To: | 99 | 50 mg | 610.00 | |
Description: (S)-2-(2-((2-(((4-(3,4-Dichlorobenzyl)morpholin-2-yl)methyl)amino)-2-oxoethyl)thio)thiazol-4-yl)acetic acid; Hazard statement: H302, H315, H319; CAS: 879399-82-3 | ||||||
| Advanced ChemBlocks CN | 10 days | China To: | 97 | 5 mg | 235.00 | |
| Advanced ChemBlocks CN | 10 days | China To: | 97 | 25 mg | 615.00 | |
| Advanced ChemBlocks CN | 10 days | China To: | 97 | 100 mg | 1,115.00 | |
Description: CCR3 antagonist 1; CAS: 879399-82-3 | ||||||
| Ambeed CN | 12 days | China To: | 99 | 5 mg | 116.10 | |
| Ambeed CN | 12 days | China To: | 99 | 10 mg | 185.40 | |
| Ambeed CN | 12 days | China To: | 99 | 25 mg | 351.00 | |
| Ambeed CN | 12 days | China To: | 99 | 50 mg | 595.80 | |
| Ambeed CN | 12 days | China To: | 99 | 100 mg | 1,012.50 | |
Description: Name: CCR3 antagonist 1; CAS: 879399-82-3 | ||||||
| Ambeed, Inc. | 12 days | United States To: | 99 | 5 mg | 116.10 | |
| Ambeed, Inc. | 12 days | United States To: | 99 | 10 mg | 185.40 | |
| Ambeed, Inc. | 12 days | United States To: | 99 | 25 mg | 351.00 | |
| Ambeed, Inc. | 12 days | United States To: | 99 | 50 mg | 595.80 | |
| Ambeed, Inc. | 12 days | United States To: | 99 | 100 mg | 1,012.50 | |
Description: Name: CCR3 antagonist 1; CAS: 879399-82-3 | ||||||
| AA BLOCKS | 12 days | United States To: | 99 | 5 mg | 125.40 | |
| AA BLOCKS | 12 days | United States To: | 99 | 10 mg | 199.10 | |
| AA BLOCKS | 12 days | United States To: | 99 | 25 mg | 377.30 | |
| AA BLOCKS | 12 days | United States To: | 99 | 50 mg | 640.20 | |
| AA BLOCKS | 12 days | United States To: | 99 | 100 mg | 1,086.80 | |
Description: CCR3 antagonist 1; CAS: 879399-82-3 | ||||||
| A2B Chem | 12 days | United States To: | 99 | 5 mg | 148.35 | |
| A2B Chem | 12 days | United States To: | 99 | 10 mg | 236.90 | |
| A2B Chem | 12 days | United States To: | 99 | 25 mg | 448.50 | |
| A2B Chem | 12 days | United States To: | 99 | 50 mg | 761.30 | |
Description: CCR3 antagonist 1; CAS: 879399-82-3 | ||||||
| Accel Scientific, S.L. | 20 days | China To: | 90 | 1 mg | 140.80 | |
| Accel Scientific, S.L. | 20 days | China To: | 90 | 5 mg | 321.20 | |
| Accel Scientific, S.L. | 20 days | China To: | 90 | 10 mg | 490.60 | |
| Accel Scientific, S.L. | 20 days | China To: | 90 | 25 mg | 768.90 | |
| Accel Scientific, S.L. | 20 days | China To: | 90 | 50 mg | 1,035.10 | |
| Accel Scientific, S.L. | 20 days | China To: | 90 | 100 mg | 1,417.90 | |
Description: CCR3 antagonist 1; CAS: 879399-82-3 | ||||||
| eNovation CN | 20 days | China To: | 99 | 10 mg | 166.75 | |
| eNovation CN | 20 days | China To: | 99 | 25 mg | 287.50 | |
| eNovation CN | 20 days | China To: | 99 | 50 mg | 465.75 | |
Description: (S)-2-(2-((2-(((4-(3,4-Dichlorobenzyl)morpholin-2-yl)methyl)amino)-2-oxoethyl)thio)thiazol-4-yl)acetic acid; CAS: 879399-82-3 | ||||||
| 10X CHEM | TBD | United States To: | 99 | 5 mg | 104.50 | |
| 10X CHEM | TBD | United States To: | 99 | 10 mg | 167.20 | |
| 10X CHEM | TBD | United States To: | 99 | 25 mg | 314.60 | |
| 10X CHEM | TBD | United States To: | 99 | 50 mg | 534.60 | |
Description: CCR3 antagonist 1; CAS: 879399-82-3 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 2-({4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl}methyl)-2,3-dihydro-1H-isoindole-1,3-dione - CSSB00025742465](/st/structure/200/bdf8ce303c49809c0a0c3b59ba8128e4/ClC1%253DCC%253DC%2528CN2CCOC%2528CN3C%2528%253DO%2529C4%253DCC%253DCC%253DC4C3%253DO%2529C2%2529C%253DC1Cl.png)
![Chemical structure of 4-{[({[(2S)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl}carbamoyl)amino]methyl}benzamide - CSSB00159269216](/st/structure/200/ac35b00715ffc03d9a4333b49e8dc453/NC%2528%253DO%2529C1%253DCC%253DC%2528CNC%2528%253DO%2529NC%255BC%2540H%255D2CN%2528CC3%253DCC%253DC%2528Cl%2529C%2528Cl%2529%253DC3%2529CCO2%2529C%253DC1.png)
![Chemical structure of 2-[2-(3,4-dimethoxyphenyl)-1,3-thiazol-4-yl]acetic acid - CSSB00000489646](/st/structure/200/d8278e9e018e5409cfde4f9d388eca84/COC1%253DCC%253DC%2528C%253DC1OC%2529C1%253DNC%2528CC%2528O%2529%253DO%2529%253DCS1.png)
![Chemical structure of 3-({2-chloro-5-ethoxy-4-[({4-[(4-fluorophenyl)methyl]morpholin-2-yl}methyl)carbamoyl]phenyl}carbamoyl)-3-hydroxypentanedioic acid - CSSB00116207717](/st/structure/200/26ff2bc1aed00a2708d7631c409620ab/CCOC1%253DCC%2528NC%2528%253DO%2529C%2528O%2529%2528CC%2528O%2529%253DO%2529CC%2528O%2529%253DO%2529%253DC%2528Cl%2529C%253DC1C%2528%253DO%2529NCC1CN%2528CC2%253DCC%253DC%2528F%2529C%253DC2%2529CCO1.png)
![Chemical structure of [(2R)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methanol - CSSB00126150535](/st/structure/200/05512cc2635b64555efd631550b6c40e/OC%255BC%2540H%255D1CN%2528CC2%253DCC%253DC%2528Cl%2529C%2528Cl%2529%253DC2%2529CCO1.png)
![Chemical structure of 2-(2-{[(4-chlorophenyl)methyl]sulfanyl}-1,3-thiazol-4-yl)acetic acid - CSSB00000510374](/st/structure/200/5da21c368cd9cc16638068d9b51f0580/OC%2528%253DO%2529CC1%253DCSC%2528SCC2%253DCC%253DC%2528Cl%2529C%253DC2%2529%253DN1.png)
![Chemical structure of 2-{2-[(3-methoxyphenyl)methyl]-1,3-thiazol-4-yl}acetic acid - CSSB00007856832](/st/structure/200/a3c43eb9bddc9d287ff88ad98bb2a9a5/COC1%253DCC%253DCC%2528CC2%253DNC%2528CC%2528O%2529%253DO%2529%253DCS2%2529%253DC1.png)
